Press releases

Investor meeting will cover Boston Scientific’s business and long-term growth strategies, including by expanding category leadership and driving global growth.

Industry's first MR-conditional directional DBS System with stimulation visualization

Results from evaluation of real-world patients presented at American Thoracic Society International Conference

Boston Scientific will participate in the healthcare conference on May 23, 2017. Learn how to watch the webcast or replay.

The first head-to-head pivotal study comparing two different TAVI platforms demonstrated the LOTUS™ Valve System’s superior efficacy.

BAcquisition expands company's structural heart portfolio; increases offerings for the treatment of patients with valvular heart disease

Largest prospective study of the WATCHMAN device presented as late-breaking trial at Heart Rhythm 2017

Analyses evaluated the impact of ethnicity, gender and income on cardiovascular outcomes

Late-breaker data presented at Heart Rhythm 2017

Pivotal data from REPRISE III and EWOLUTION among four late-breaking clinical trials to be presented